Market Value2,874,475,000
Total Holdings71
File Date2021-11-22
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IGMS / IGM Biosciences, Inc.
ALVR / AlloVir, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
CMAXW / CareMax Inc - Warrants (08/06/2026)
CRBU / Caribou Biosciences, Inc.
TNGX / Tango Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
FSTX / F-star Therapeutics Inc
KRON / Kronos Bio, Inc.
BCEL / Atreca, Inc.
AKUS / Akouos Inc
BOLT / Bolt Biotherapeutics, Inc.
NUVB / Nuvation Bio Inc.
BPMC / Blueprint Medicines Corporation Call
KYMR / Kymera Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
CRVS / Corvus Pharmaceuticals, Inc.
RCUS / Arcus Biosciences, Inc.
PRTA / Prothena Corporation plc
SLDB / Solid Biosciences Inc.
FMTX / Forma Therapeutics Holdings Inc
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
PRDS / Pardes Biosciences Inc
G2445M111 / Consonance-HFW Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary S
TBIO / Telesis Bio, Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
ARYD / ARYA Sciences Acquisition Corp IV
KYG9127T1242 / WARRANTS
ANAB / AnaptysBio, Inc.
ALPN / Alpine Immune Sciences, Inc.
SBTX / Silverback Therapeutics Inc
ODT / Odonate Therapeutics Inc
MGTA / Magenta Therapeutics Inc
IMVT / Immunovant, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
SRZN / Surrozen, Inc.
JYAC / Jiya Acquisition Corp - Class A
SYRS / Syros Pharmaceuticals, Inc.
KNTE / Kinnate Biopharma Inc.
TMPM / Turmeric Acquisition Corp - Class A
FVAM / 5:01 Acquisition Corp.
OMEG / Omega Alpha SPAC - Class A
FLAC / Frazier Lifesciences Acquisition Corp - Class A
EWTX / Edgewise Therapeutics, Inc.
MGTX / MeiraGTx Holdings plc
ACIU / AC Immune SA
HLXA / Helix Acquisition Corp - Class A
CCCC / C4 Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
RPTX / Repare Therapeutics Inc.
NRIX / Nurix Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
DRNA / Dicerna Pharmaceuticals Inc
SRRK / Scholar Rock Holding Corporation
NGM / NGM Biopharmaceuticals, Inc.
BLSA / BCLS Acquisition Corp - Class A
BCAB / BioAtla, Inc.
PTGX / Protagonist Therapeutics, Inc.
STTK / Shattuck Labs, Inc.
BLUE / bluebird bio, Inc.
NGM / NGM Biopharmaceuticals, Inc. Call
ARVN / Arvinas, Inc.
ERAS / Erasca, Inc.
ALEC / Alector, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
MORF / Morphic Holding, Inc.
CYCN / Cyclerion Therapeutics, Inc.
VYGR / Voyager Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
KURA / Kura Oncology, Inc.
PMVP / PMV Pharmaceuticals, Inc.
GRTS / Gritstone bio, Inc.
ITOS / iTeos Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
XNCR / Xencor, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
JANX / Janux Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.